Mayer Brown Webinar – Financing Alternatives for Life Sciences Companies

By Mayer Brown on January 8, 2019

Posted in Capital Formation, Events, Mezzanine/Pre-IPO Private Placements, PIPEs

Thursday, February 7, 2019
1:00 p.m. – 2:00 p.m. ET

The U.S. capital markets remain an attractive source of capital for emerging companies in the life sciences sector. Over 21.7% of the 2017 IPOs were life sciences companies. Many of these IPOs were preceded by late stage (or mezzanine) private placements made principally to U.S. institutional investors.

In our session, partners Anna Pinedo and David Bakst will focus on:

Financing alternatives for pre-IPO companies;
The late-stage (or “cross-over”) private placement market;
Considering milestones when planning a financing strategy; and
Post-IPO alternatives, including registered direct offerings, PIPE transactions, at the market offerings, and related financing considerations

To register, please click here.